SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merge Healthcare Inc.
MRGE 0.002000.0%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: E_K_S who wrote (121)4/28/2015 10:28:07 PM
From: Sultan   of 134
 
Thanks..

I was happy with the CC and prospects going forward.. I have no plans to sell for at least next 12-18 months while we start to see growth.. I think management is being cautious with $ 248m run rate.. Any case, target share price of $8 - 9 is not out of line.. Longer term, I still think either they will bulk up some more or they will be taken out by a bigger outfit..

There are many positive comments sprinkled during the CC, compared to previous CC..

Some notable comments:

In addition to being wins in their own right, we also displaced competitive imaging products with Merge solutions at the combination of more than 40 hospitals and health systems across the country. The quarter saw four seven figure deals, including three cardiology and one major radiology PACS
We won a system-wide cardiology contract with one of the nation’s leading health systems, comprising a 1,000 integrated care sites and more than 7,000 beds. As a result of the transaction structure however, we do not record any revenue on this contract in the first quarter of 2015. We expect to recognize revenue for this multi-million dollar transaction ratably over multiple years.

We also secured an additional seven figure cardiology contract with eight hospitals faith-based non-profit hospital group. This transaction also resulted in zero revenue in the quarter. However, we expect the majority of the revenue from this transaction to be recorded in the second half of 2015. In addition, we continue to expand our footprint in the radiology PACS market as health systems allocate funds to upgrades and system replacements.
D.R. Systems had only one month of revenue contribution to the Healthcare segment and $2.6 million of the total $2.8 million was maintenance.
In response to question re. D.R. Systems revenue run rate ..
they have been fairly constant the last three to four years at roughly about $40 million of revenue and $10 million of margin off of that, as you bring it down the line.

We recorded an $18.4 million non-cash income tax benefit related to the release of total Merge tax asset valuation allowances based on corresponding tax liabilities established in the acquisition, primarily from future tax rates associated with intangible assets acquired. By immediately unlocking this value and the consolidated Merge tax structure, it’s like saying the cost of D. R. Systems was closer to $52 million versus the net purchase price of $70 million. Said differently, the accretive nature of the transaction has risen significantly from the last time we discussed.

Any case, let's see how the year progresses..
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext